dermatology
Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness
October 3, 2025Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology
The current forms of immunotherapy, how T cell therapy works and what the future holds
LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
July 7, 2025Manufacturing and Production Dermatology, Helle Hedegaard Juhl, LEO Pharma, Skin, dermatology
Danish dermatology company, LEO Pharma, announced the appointment of new executive vice president (EVP) of global people and corporate affairs, …
Mallia strengthens its advisory board as it accelerates hair loss treatment
July 7, 2025Manufacturing and Production Dermatology, Skin, biopharma, dermatology, hair loss, mallia
German dermatology company, Mallia Innovations, has appointed Jens Holstein, Alexandra Ogilvie and Ulrich Dauer to its advisory board, strengthening its …
Galderma launches clinical trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin
June 27, 2025Research and Development Dermatology, Galderma, chronic pruritus of unknown origin, clinical trials, dermatological conditions, dermatology, nemolizumab, systemic sclerosis
Galderma has announced the launch of two phase 2 clinical trials evaluating its monoclonal antibody, nemolizumab, in two conditions: systemic …
Dupixent improves symptoms in patients with skin of colour, study shows
June 11, 2025Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations
Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …
UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study
May 28, 2025Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology
Masami Ando Kuri from the Wellcome Sanger Institute named one of six global winners of the 2024 IBSA Foundation Fellowships. …
Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment
February 23, 2024Research and Development Almirall, Dermatology, Novo Nordisk, dermatology, monoclonal antibody
Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk for the rights to its …
Eli Lilly shares positive analysis from phase 3 trial for lebrikizumab for atopic dermatitis
May 3, 2023Research and Development Dermatology, Eli Lilly, Jenny Murase, atopic dermatitis, dermatology, lebrikizumab
Eli Lilly has announced new secondary analysis from its phase 3 clinical development programme for patients with atopic dermatitis (AD) …
Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis
March 31, 2023Business Services Almirall, Dermatology, dermatology, lebrikizumab
BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …
Global orphan and rare dermatology market set to exceed $6 billion by 2024
August 31, 2018Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases
The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
Almirall picks up Allergan’s dermatology portfolio to for $650m
August 3, 2018Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma
Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …
Artificial skin development has implications for clinical trials
January 23, 2017Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology
Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …
Almirall to acquire Poli Group’s skin drugs
November 30, 2015Sales and Marketing Almirall, Poldi, dermatology, skin, specialty pharma
Almirall has agreed to acquire 100% of the share capital of Poli Group Holding as the Spanish pharma company continues …
LEO Pharma buys dermatology portfolio from Astellas
November 12, 2015Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers
LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …
Novartis emphasises pharma growth
June 19, 2014Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory
Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …
